Not So Different: A Podcast From The Center For Biosimilars

S6 Ep7: Pipelines and Preparation: How the US Can Prepare for More RA Biosimilars

Informações:

Sinopsis

To learn more about biosimilars to treat RA, click here. To learn more about rheumatologists’ perceptions about RA biosimilars, click here. To learn more about incentives for prescribing biosimilars, click here. To learn more about infliximab biosimilar adoption, click here. To learn more about the influx of adalimumab biosimilars to the US market, click here. To learn more about ustekinumab biosimilars, click here.